SCHEMBL4209762

SCHEMBL4209762

CN(C)CCCCCCNc1ncc(Cl)c(-c2cc3c(C(=O)NC4CC4)cccc3s2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 3/20 0.39
TYRO3 Q06418 15/20 0.39
MERTK Q12866 12/20 0.39
FLT3 P36888 10/20 0.39
GAS6 Q14393 9/20 0.39
SELP P16109 3/20 0.39
AXL P30530 6/20 0.37
CHEK1 O14757 1/20 0.37
IKBKB O14920 1/20 0.37
AURKA O14965 1/20 0.37
PAK4 O96013 1/20 0.37
CHEK2 O96017 1/20 0.37
ABL1 P00519 1/20 0.37
EGFR P00533 1/20 0.37
INSR P06213 1/20 0.37
LCK P06239 1/20 0.37
CSNK2A2 P19784 1/20 0.37
CCNA2 P20248 1/20 0.37
CDK2 P24941 1/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3966655 1.00 FGFR1 (0.39) FGFR1TYRO3MERTKFLT3GAS6
SCHEMBL3961953 0.88 CCNT1 (0.39) FGFR1TYRO3MERTKFLT3GAS6
Hydrochloric Acid SCHEMBL3963698 0.86 AXL (0.38) FGFR1TYRO3MERTKFLT3GAS6
Hydrochloric Acid SCHEMBL3961560 0.85 FGFR1 (0.47) FGFR1TYRO3MERTKFLT3GAS6
SCHEMBL4073584 0.85 FGFR1 (0.49) FGFR1TYRO3MERTKFLT3GAS6
Hydrochloric Acid SCHEMBL4084184 0.85 FGFR1 (0.49) FGFR1AXLEGFR
Hydrochloric Acid SCHEMBL3961798 0.85 FGFR1 (0.49) FGFR1AXLEGFR
SCHEMBL3961942 0.85 P2RX7 (0.38) FGFR1TYRO3MERTKFLT3GAS6
Hydrochloric Acid SCHEMBL3961965 0.85 TYRO3 (0.45) FGFR1TYRO3MERTKFLT3GAS6
Hydrochloric Acid SCHEMBL3966596 0.84 TYRO3 (0.45) FGFR1TYRO3MERTKFLT3GAS6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1989200-B1 [4-(BENZO[B]THIOPHEN-2-YL)-PYRIMIDIN-2-YL]-AMINE DERIVATIVES AS IKK-BETA INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES LILLY CO ELI (US) 2009-07-29 EP disclosed